# KE Holdings Inc.: Form 20-F for the period ended Dec 31, 2020

- Company: [KE Holdings Inc.](/companies/beke.md) (CIK 1809587)
- Form: 20-F
- Filed: 2021-04-06
- Accepted by EDGAR: Apr 6, 2021, 08:10 ET
- Period: 2020-12-31
- Accession: 0001104659-21-046841
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1809587/000110465921046841/beke-20201231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1809587/000110465921046841/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2020-01-01 to 2020-12-31 | $10.80bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2020-01-01 to 2020-12-31 | $8.22bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2020-01-01 to 2020-12-31 | $2.58bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2020-01-01 to 2020-12-31 | $379.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2020-01-01 to 2020-12-31 | $435.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2020-01-01 to 2020-12-31 | CNY 188.4m | us-gaap:InterestExpense |
| Income tax | 12 months, 2020-01-01 to 2020-12-31 | $246.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2020-01-01 to 2020-12-31 | $425.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2020-01-01 to 2020-12-31 | $0.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2020-01-01 to 2020-12-31 | $0.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2020-01-01 to 2020-12-31 | 2,267,330,891 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2020-01-01 to 2020-12-31 | $1.43bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2020-01-01 to 2020-12-31 | $135.9m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | at 2020-12-31 | $6.28bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-12-31 | $13.42bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-12-31 | $15.98bn | us-gaap:Assets |
| Current liabilities | at 2020-12-31 | $5.15bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-12-31 | $5.75bn | us-gaap:Liabilities |
| Shareholders' equity | at 2020-12-31 | $10.23bn | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1809587/000110465921046841/beke-20201231x20f.htm

Filed Apr 6, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-046841. Last ingested by Listed: Nov 9, 2026, 17:05 ET. No prices; not investment advice.